-
Stocks to Watch: The Dow Chemical Company (NYSE:DOW), Southwestern Energy Co. (NYSE:SWN), TG Therapeutics (NASDAQ:TGTX), Peregrine Pharmaceuticals (NASDAQ:PPHM), Valeant Pharmaceuticals (NYSE:VRX)
On 5 December The Dow Chemical Company (NYSE:DOW) agreed to sell its global Sodium Borohydride business to Vertellus Specialty Materials LLC and its Findlay, Ohio-based polyolefin films plant to Valfilm North America, Inc., an unit of Valgroup Packaging Solutions for total proceeds around $225 million. The Dow Chemical Company (NYSE:DOW) in last trading activity fell…
-
Stocks in Focus: LifeLock (NYSE:LOCK), Atlas Resource Partners, L.P. (NYSE:ARP), Callidus Software Inc. (NASDAQ:CALD), Authentidate Holding Corp. (NASDAQ:ADAT), TG Therapeutics (NASDAQ:TGTX)
LifeLock, Inc. (NASDAQ:LOCK) Insider Clarissa Cerda sold 3,000 shares of Lifelock stock in a transaction dated Wednesday, December 24th. The stock was sold at an average price of $17.36, for a total transaction of $52,080.00. Following the transaction, the insider now directly owns 11,396 shares of the company’s stock, valued at approximately $197,835. LifeLock, Inc.…
-
Stocks Swings: Sangamo Biosciences Inc. (NASDAQ:SGMO), TG Therapeutics (NASDAQ:TGTX), Teekay Offshore Partners (NYSE:TOO), Kennedy-Wilson (NYSE:KW), Hannon Armstrong Sustnbl Infrstr Cap (NYSE:HASI)
Sangamo Biosciences Inc. ( (NASDAQ:SGMO) CEO Edward O. Lanphier II sold 25,000 shares of the stock on the open market in a transaction that occurred on Monday, December 15th. The shares were sold at an average price of $15.40, for a total value of $385,000.00. Following the sale, the chief executive officer now directly owns…
-
Morning Alert: Jumei International Holding Limited (NYSE:JMEI), TG Therapeutics (NASDAQ:TGTX), Danaher Corp. (NYSE:DHR), Harmonic Inc. (NASDAQ:HLIT), National Penn Bancshares Inc. (NASDAQ:NPBC)
Jumei International Holding Limited (NYSE:JMEI) announced that its board of directors has authorized a share repurchase program under which the Company may repurchase up to US$100 million of its shares over the next 12 months. Jumei International Holding Limited (NYSE:JMEI) in last trading activity advanced 11.50% to close at $15.42. Company weekly performance is 14.14%…
-
Healthcare week’s top 20 % gainers: Calithera Biosciences (NASDAQ:CALA), bluebird (NASDAQ:BLUE), Sangamo Biosciences (NASDAQ:SGMO), ARCA biopharma (NASDAQ:ABIO), Medgenics (NYSEMKT:MDGN), TG Therapeutics (NASDAQ:TGTX)
Calithera Biosciences, Inc. (NASDAQ:CALA) on Dec. 10 announced results of studies with primary human breast tumors that support glutaminase as a potential target in triple negative breast cancer (TNBC). Using a novel pharmacodynamic assay designed to measure the extent of glutaminase inhibition in a single post-dose tumor biopsy sample, significant glutaminase inhibition was observed following…
-
Traders Alert: Apple Inc. (NASDAQ:AAPL), TG Therapeutics (NASDAQ:TGTX), JMP Group Inc. (NYSE:JMP), Spirit AeroSystems Holdings (NYSE:SPR), Bitauto Holdings Limited (NYSE:BITA)
A California federal judge on Friday refused to reconsider an October ruling finding Apple Inc. (NASDAQ:AAPL)’s iPhones and iPads don’t infringe two wireless-communication technology patents owned by Wi-LAN Inc., saying Wi-LAN failed to show any evidence that he made that ruling in error. Apple Inc. (NASDAQ:AAPL) in last trading activity moved down -1.69% to close…
-
Investors Should Watch: Genworth Financial (NYSE:GNW), Twitter Inc (NYSE:TWTR), S&W Seed Company (NASDAQ:SANW), Cisco Systems (NASDAQ:CSCO), TG Therapeutics (NASDAQ:TGTX)
Shares of Genworth Financial Inc (NYSE:GNW) were the recipient of a large increase in short interest in November. As of November 14th, there was short interest totalling 10,236,097 shares, an increase of 78.2% from the October 31st total of 5,743,310 shares. Genworth Financial, Inc. (NYSE:GNW) in last trading activity advanced 0.98% to close at $8.24.…
-
Must Watch These 5 Stocks: Gilead Sciences Inc. (NASDAQ:GILD), TG Therapeutics (NASDAQ:TGTX), Tiptree Financial (NASDAQ:TIPT), Seagate Technology (NASDAQ:STX), Gulfport Energy (NASDAQ:GPOR)
Gilead Sciences (NASDAQ:GILD) COO John F. Milligan sold 146,823 shares of Gilead Sciences stock on the open market in a transaction dated Monday, December 8th. The stock was sold at an average price of $106.26, for a total transaction of $15,601,411.98. Following the sale, the chief operating officer now directly owns 974,048 shares of the…
-
Biotech Gainers: Arrowhead Research Corp. (NASDAQ:ARWR), TG Therapeutics (NASDAQ:TGTX), Agios Pharmaceuticals (NASDAQ:AGIO), Sangamo Biosciences Inc. (NASDAQ:SGMO), Discovery Laboratories Inc. (NASDAQ:DSCO)
Law Offices of Howard G. Smith on Dec. 1 announced that a class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of purchasers of the common stock of Arrowhead Research Corporation (NASDAQ:ARWR) between August 12, 2014 and October 8, 2014, inclusive (the “Class Period”).…
-
Infinity Pharmaceuticals (NASDAQ:INFI) reported updated data from a Phase 1 monotherapy study: TG Therapeutics (NASDAQ:TGTX), VIVUS (NASDAQ:VVUS), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind (NASDAQ:MNKD)
Infinity Pharmaceutical Inc. (NASDAQ:INFI) reported updated data from a Phase 1 monotherapy study of duvelisib; shows Duvelisib activity as a monotherapy in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma and Relapsed/Refractory T-Cell Lymphoma. Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) in last trading activity increased 4.62% to close at $17.21. Company weekly performance is 11.97% while its quarterly performance stands at…